NCT03078374View on ClinicalTrials.gov

MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

January 31, 2022

Study Completion Date

October 31, 2022

Conditions
Heart FailureCardiovascular Diseases
Interventions
DRUG

Warfarin

Reduced dosage to obtain lower INR range

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV